Sensex rises 308 points, Nifty clears 23,000 as IT and pharma lead 2nd straight gain
Synopsis
Key Takeaways
Indian equity benchmarks closed higher for the second consecutive session on Friday, 30 October, powered by strong buying in IT and pharma stocks, even as the broader market stayed under pressure. The BSE Sensex advanced 308.49 points, or 0.42%, to settle at 74,459.53, while the Nifty50 gained 116.35 points, or 0.51%, to close at 23,053.10 — decisively reclaiming its 20-day moving average (20-DMA).
What Drove the Rally
A key catalyst was the global unwinding of crowded artificial intelligence (AI)-linked trades, which redirected capital toward domestic technology stocks and lifted sentiment. The strength in heavyweight IT companies helped Indian equities outperform most of their Asian counterparts during the session.
Among Nifty50 constituents, Trent, InterGlobe Aviation, and Infosys emerged as the top gainers, leading the benchmark's advance. The Nifty IT index was the session's best-performing sector, while pharma shares also attracted strong buying interest on the back of encouraging earnings and defensive demand.
Broader Market Lags
Despite the frontline rally, the broader market remained under stress. The Nifty MidCap 100 index declined 0.93%, while the Nifty SmallCap 100 index fell 1.85% — a sign that the buying was concentrated rather than broad-based. The Nifty Consumer Durables index ended as the biggest sectoral loser of the day.
This divergence between large-caps and mid- and small-caps suggests that institutional money is rotating selectively, gravitating toward defensives and blue-chip IT rather than making a broad risk-on bet.
Technical Outlook
Market analysts noted that after several sessions of consolidation, the Nifty witnessed a meaningful breakout, closing above the crucial 22,800 level. On the 3-hour chart, a symmetrical triangle pattern is developing, with a breakout above 23,250 required for further confirmation of the uptrend.
'The short-term outlook remains positive as long as the index sustains above 22,800,' analysts stated. They further advised that 'traders can consider booking partial profits near 23,250 while holding the remaining long positions with a trailing stop-loss of 22,950.'
Sectoral Snapshot
'Large-caps showed relative resilience, supported by IT, where selective buying emerged amid a rotation away from global AI plays, while pharma and healthcare gained on encouraging earnings and defensive demand,' according to market experts. The mixed sectoral performance underscores a market navigating between global risk recalibration and domestic earnings momentum — a tug-of-war likely to persist into the next trading week.